Stericycle, Inc. (NASDAQ:SRCL) Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $67.43, for a total transaction of $1,331,944.79. The transaction was disclosed in a filing with the SEC, which is available through this link.

Shares of Stericycle, Inc. (NASDAQ SRCL) opened at $66.95 on Friday. The company has a market cap of $5,677.30, a PE ratio of 15.32, a price-to-earnings-growth ratio of 1.62 and a beta of 0.16. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82. Stericycle, Inc. has a 12-month low of $61.25 and a 12-month high of $88.00.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.04). The company had revenue of $883.00 million during the quarter, compared to the consensus estimate of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The business’s revenue was down .8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.24 EPS. equities analysts forecast that Stericycle, Inc. will post 4.49 EPS for the current year.

A number of research firms recently weighed in on SRCL. William Blair reissued an “ourperform” rating on shares of Stericycle in a research report on Thursday, September 14th. Zacks Investment Research lowered shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Jefferies Group set a $108.00 price target on shares of Stericycle and gave the company a “buy” rating in a research report on Tuesday, October 17th. Stifel Nicolaus reissued a “buy” rating and set a $85.00 price target (down from $95.00) on shares of Stericycle in a research report on Thursday, November 9th. Finally, Royal Bank Of Canada dropped their price target on shares of Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a research report on Thursday, November 9th. Four investment analysts have rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. Stericycle presently has a consensus rating of “Hold” and an average price target of $76.73.

A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in Stericycle by 3.0% in the second quarter. Vanguard Group Inc. now owns 8,334,537 shares of the business services provider’s stock worth $636,092,000 after acquiring an additional 240,327 shares during the period. BlackRock Inc. raised its position in Stericycle by 6.4% in the second quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock worth $413,139,000 after acquiring an additional 323,664 shares during the period. Schroder Investment Management Group raised its position in Stericycle by 89.3% in the third quarter. Schroder Investment Management Group now owns 1,973,743 shares of the business services provider’s stock worth $141,556,000 after acquiring an additional 931,300 shares during the period. Wells Fargo & Company MN raised its position in Stericycle by 7.1% in the third quarter. Wells Fargo & Company MN now owns 1,898,959 shares of the business services provider’s stock worth $136,003,000 after acquiring an additional 126,005 shares during the period. Finally, Jennison Associates LLC increased its stake in shares of Stericycle by 0.4% in the third quarter. Jennison Associates LLC now owns 1,494,643 shares of the business services provider’s stock worth $107,046,000 after purchasing an additional 5,522 shares in the last quarter. 94.63% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Stericycle, Inc. (SRCL) Director Sells $1,331,944.79 in Stock” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://theolympiareport.com/2017/12/08/insider-selling-stericycle-inc-srcl-director-sells-1331944-79-in-stock.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.